ABCELLERA BIOLOGICS INC
ABCLNASDAQ🏆 #1448 by market capEarnings Nov 4US Equity
$14.82▲ $0.96 (+6.47%)
🌙 After hours$14.97▲ 1.01%Regular close · extended-hours price shownTrack ABCL
Get earnings, price moves & breaking news on Telegram
24h▲ 6.5%
7d▲ 17.2%
14d▲ 30.0%
30d▲ 30.6%
ytd▲ 334.6%
1y▲ 204.3%
🏦Market Cap
$4.53B
Small Cap
📈Revenue Growth (YoY)
+160.6%
High Growth
📊Gross Margin
75.0%
High
💵FCF Margin
-271.2%
Thin
⚖️P/S Ratio
64.2x
Expensive
Otter Score
68
Fair
ABCELLERA BIOLOGICS INC
ABCLAnalyst Ratings
Price
$14.82
Total
12
Raised
1
Lowered
1
Avg PT
$14.75
H / L
$30 / $7
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Truist Securities | Reiterated | Buy | 2026-08-11 | — | — |
Stifel | Reiterated | Buy | 2026-08-06 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2026-08-06 | $7.00 | −52.80% |
Benchmark | Upgraded | Hold → Buy | 2026-07-07 | — | — |
Leerink Partners | Downgraded | Outperform → Market Perform | 2025-11-07 | $18.00 | +21.50% |
Keybanc | Reiterated | Overweight | 2025-07-14 | $5.00 | −66.30% |
Goldman Sachs | Reiterated | Buy | 2023-08-04 | $13.00 | −12.30% |
Credit Suisse | Reiterated | Outperform | 2023-05-05 | $34.00 | +129.40% |
Cowen & Co. | Reiterated | Outperform | 2023-02-28 | — | — |
BMO Capital | Reiterated | Outperform | 2023-02-22 | $5.00 | −66.30% |
SVB Leerink | Reiterated | Outperform | 2023-01-06 | — | — |
Piper Sandler | Reiterated | Overweight | 2022-07-26 | — | — |
Institution
Truist Securities
Reiterated · Buy · 2026-08-11
—
—
Stifel
Reiterated · Buy · 2026-08-06
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2026-08-06
$7.00
−52.80%
Benchmark
Upgraded · Hold → Buy · 2026-07-07
—
—
Leerink Partners
Downgraded · Outperform → Market Perform · 2025-11-07
$18.00
+21.50%
Keybanc
Reiterated · Overweight · 2025-07-14
$5.00
−66.30%
Goldman Sachs
Reiterated · Buy · 2023-08-04
$13.00
−12.30%
Credit Suisse
Reiterated · Outperform · 2023-05-05
$34.00
+129.40%
Cowen & Co.
Reiterated · Outperform · 2023-02-28
—
—
BMO Capital
Reiterated · Outperform · 2023-02-22
$5.00
−66.30%
SVB Leerink
Reiterated · Outperform · 2023-01-06
—
—
Piper Sandler
Reiterated · Overweight · 2022-07-26
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space